Tenax Historical Balance Sheet

TENX Stock

USD 5.72 0.36 6.72%

Trend analysis of Tenax Therapeutics balance sheet accounts such as Total Stockholder Equity of 12.7 M, Property Plant And Equipment Net of 0.0, Accounts Payable of 2.2 M or Cash of 9.6 M provides information on Tenax Therapeutics' total assets, liabilities, and equity, which is the actual value of Tenax Therapeutics to its prevalent stockholders. By breaking down trends over time using Tenax Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Tenax Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Tenax Therapeutics is a good buy for the upcoming year.

Tenax Therapeutics Inventory

401,964

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenax Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.

About Tenax Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Tenax Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Tenax Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Tenax Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Tenax currently owns. An asset can also be divided into two categories, current and non-current.

Tenax Therapeutics Balance Sheet Chart

At this time, Tenax Therapeutics' Non Currrent Assets Other are fairly stable compared to the past year. Other Liabilities is likely to rise to about 9.6 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 790.7 K in 2024.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Tenax Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Tenax Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Tenax Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Tenax Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Tenax Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Tenax Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenax Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.At this time, Tenax Therapeutics' Non Currrent Assets Other are fairly stable compared to the past year. Other Liabilities is likely to rise to about 9.6 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 790.7 K in 2024.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	290.8K	807.9K	500.9K	589.8K
Total Assets	6.0M	3.4M	11.7M	15.5M

Short Long Term Debt Total Total Assets

Tenax Therapeutics balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Common Stock Total Equity	Property Plant And Equipment Gross	Non Currrent Assets Other	Property Plant Equipment	Other Assets	Long Term Debt
Total Assets		-0.22	0.19	0.13	1.0	-0.17	-0.99	0.27	-0.14	0.99	0.76	1.0	0.34	0.91	-0.13	0.11	0.89	1.0	0.26	-0.19	-0.19	-0.2	-0.53	-0.39	0.02	-0.31
Short Long Term Debt Total	-0.22		-0.04	-0.04	-0.26	0.72	0.28	0.33	-0.03	-0.23	-0.13	-0.25	-0.2	0.17	-0.17	-0.43	0.16	-0.25	-0.22	-0.1	-0.1	0.73	0.09	0.35	-0.16	0.56
Other Current Liab	0.19	-0.04		0.83	0.16	-0.2	-0.14	0.05	-0.13	0.14	0.33	0.16	-0.07	0.11	-0.17	0.01	0.38	0.16	-0.17	-0.18	-0.18	-0.18	-0.06	-0.35	0.05	-0.06
Total Current Liabilities	0.13	-0.04	0.83		0.11	-0.29	-0.1	-0.19	0.36	0.1	0.16	0.1	0.3	0.01	0.31	0.25	0.34	0.11	-0.03	-0.33	-0.33	-0.23	0.02	-0.27	-0.16	0.02
Total Stockholder Equity	1.0	-0.26	0.16	0.11		-0.2	-1.0	0.25	-0.14	0.99	0.76	1.0	0.34	0.9	-0.12	0.13	0.87	1.0	0.27	-0.18	-0.18	-0.23	-0.53	-0.4	0.03	-0.33
Property Plant And Equipment Net	-0.17	0.72	-0.2	-0.29	-0.2		0.2	0.46	-0.31	-0.17	-0.07	-0.2	-0.26	0.17	-0.47	-0.56	0.11	-0.2	-0.22	0.14	0.14	0.98	0.03	0.52	0.08	0.6
Net Debt	-0.99	0.28	-0.14	-0.1	-1.0	0.2		-0.22	0.1	-1.0	-0.74	-1.0	-0.36	-0.88	0.09	-0.16	-0.85	-1.0	-0.28	0.19	0.19	0.24	0.52	0.39	-0.01	0.34
Retained Earnings	0.27	0.33	0.05	-0.19	0.25	0.46	-0.22		-0.53	0.24	0.28	0.23	-0.19	0.47	-0.62	-0.93	0.39	0.23	-0.27	0.6	0.6	0.37	-0.18	0.27	0.67	0.45
Accounts Payable	-0.14	-0.03	-0.13	0.36	-0.14	-0.31	0.1	-0.53		-0.11	-0.38	-0.12	0.74	-0.24	0.82	0.52	-0.11	-0.11	0.05	-0.31	-0.3	-0.22	0.23	-0.05	-0.42	-0.19
Cash	0.99	-0.23	0.14	0.1	0.99	-0.17	-1.0	0.24	-0.11		0.75	1.0	0.35	0.91	-0.1	0.13	0.87	1.0	0.27	-0.19	-0.19	-0.2	-0.53	-0.37	0.01	-0.32
Non Current Assets Total	0.76	-0.13	0.33	0.16	0.76	-0.07	-0.74	0.28	-0.38	0.75		0.75	-0.18	0.71	-0.27	0.0	0.72	0.75	0.16	-0.12	-0.12	-0.14	-0.66	-0.37	0.17	-0.19
Cash And Short Term Investments	1.0	-0.25	0.16	0.1	1.0	-0.2	-1.0	0.23	-0.12	1.0	0.75		0.34	0.9	-0.12	0.14	0.87	1.0	0.26	-0.21	-0.21	-0.23	-0.53	-0.41	0.0	-0.34
Common Stock Shares Outstanding	0.34	-0.2	-0.07	0.3	0.34	-0.26	-0.36	-0.19	0.74	0.35	-0.18	0.34		0.2	0.57	0.34	0.29	0.35	0.21	-0.18	-0.18	-0.2	0.05	-0.14	-0.23	-0.28
Non Current Liabilities Total	0.91	0.17	0.11	0.01	0.9	0.17	-0.88	0.47	-0.24	0.91	0.71	0.9	0.2		-0.31	-0.14	0.94	0.9	0.12	-0.18	-0.18	0.14	-0.5	-0.25	0.0	-0.06
Other Current Assets	-0.13	-0.17	-0.17	0.31	-0.12	-0.47	0.09	-0.62	0.82	-0.1	-0.27	-0.12	0.57	-0.31		0.62	-0.19	-0.1	0.51	-0.23	-0.22	-0.39	0.15	0.08	-0.31	-0.26
Other Stockholder Equity	0.11	-0.43	0.01	0.25	0.13	-0.56	-0.16	-0.93	0.52	0.13	0.0	0.14	0.34	-0.14	0.62		-0.07	0.15	0.37	-0.68	-0.68	-0.48	-0.02	-0.42	-0.67	-0.58
Total Liab	0.89	0.16	0.38	0.34	0.87	0.11	-0.85	0.39	-0.11	0.87	0.72	0.87	0.29	0.94	-0.19	-0.07		0.87	0.13	-0.27	-0.27	0.09	-0.46	-0.29	-0.04	-0.02
Total Current Assets	1.0	-0.25	0.16	0.11	1.0	-0.2	-1.0	0.23	-0.11	1.0	0.75	1.0	0.35	0.9	-0.1	0.15	0.87		0.27	-0.21	-0.21	-0.23	-0.52	-0.41	-0.01	-0.34
Short Term Debt	0.26	-0.22	-0.17	-0.03	0.27	-0.22	-0.28	-0.27	0.05	0.27	0.16	0.26	0.21	0.12	0.51	0.37	0.13	0.27		0.04	0.03	-0.23	-0.16	0.27	0.05	-0.36
Common Stock	-0.19	-0.1	-0.18	-0.33	-0.18	0.14	0.19	0.6	-0.31	-0.19	-0.12	-0.21	-0.18	-0.18	-0.23	-0.68	-0.27	-0.21	0.04		1.0	0.03	0.06	0.63	0.95	0.06
Common Stock Total Equity	-0.19	-0.1	-0.18	-0.33	-0.18	0.14	0.19	0.6	-0.3	-0.19	-0.12	-0.21	-0.18	-0.18	-0.22	-0.68	-0.27	-0.21	0.03	1.0		0.03	0.06	0.62	0.95	0.06
Property Plant And Equipment Gross	-0.2	0.73	-0.18	-0.23	-0.23	0.98	0.24	0.37	-0.22	-0.2	-0.14	-0.23	-0.2	0.14	-0.39	-0.48	0.09	-0.23	-0.23	0.03	0.03		0.15	0.48	-0.04	0.61
Non Currrent Assets Other	-0.53	0.09	-0.06	0.02	-0.53	0.03	0.52	-0.18	0.23	-0.53	-0.66	-0.53	0.05	-0.5	0.15	-0.02	-0.46	-0.52	-0.16	0.06	0.06	0.15		0.22	-0.1	0.14
Property Plant Equipment	-0.39	0.35	-0.35	-0.27	-0.4	0.52	0.39	0.27	-0.05	-0.37	-0.37	-0.41	-0.14	-0.25	0.08	-0.42	-0.29	-0.41	0.27	0.63	0.62	0.48	0.22		0.48	0.31
Other Assets	0.02	-0.16	0.05	-0.16	0.03	0.08	-0.01	0.67	-0.42	0.01	0.17	0.0	-0.23	0.0	-0.31	-0.67	-0.04	-0.01	0.05	0.95	0.95	-0.04	-0.1	0.48		0.0
Long Term Debt	-0.31	0.56	-0.06	0.02	-0.33	0.6	0.34	0.45	-0.19	-0.32	-0.19	-0.34	-0.28	-0.06	-0.26	-0.58	-0.02	-0.34	-0.36	0.06	0.06	0.61	0.14	0.31	0.0

Click cells to compare fundamentals

Tenax Therapeutics Account Relationship Matchups

Tenax Therapeutics balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	6.4M	6.9M	6.0M	3.4M	11.7M	15.5M
Other Current Liab	760.0K	1.2M	597.1K	655.7K	1.0M	790.7K
Total Current Liabilities	2.5M	2.1M	1.6M	1.8M	3.6M	3.8M
Total Stockholder Equity	3.8M	4.6M	4.2M	1.5M	8.1M	12.7M
Property Plant And Equipment Net	8.5K	176.0K	64.8K	294.8K	186.7K	0.0
Net Debt	(4.7M)	(5.9M)	(5.3M)	(1.3M)	(9.3M)	(9.8M)
Retained Earnings	(236.2M)	(246.0M)	(278.5M)	(289.5M)	(297.3M)	(282.4M)
Accounts Payable	1.7M	757.9K	859.6K	448.4K	2.1M	2.2M
Cash	4.9M	6.3M	5.6M	2.1M	9.8M	9.6M
Non Current Assets Total	184.4K	73.2K	303.2K	196.2K	1.1K	1.1K
Cash And Short Term Investments	5.4M	6.7M	5.6M	2.1M	9.8M	10.0M
Common Stock Shares Outstanding	309.8K	6.5K	12.9K	18.4K	248.4K	260.9K
Liabilities And Stockholders Equity	6.4M	6.9M	6.0M	3.4M	11.7M	15.5M
Non Current Liabilities Total	749.8K	60.4K	124.2K	183.6K	64.2K	0.0
Other Current Assets	781.0K	82.6K	105.1K	1.1M	1.9M	2.0M
Other Stockholder Equity	239.9M	250.6M	282.7M	291.0M	305.4M	320.6M
Total Liab	2.6M	2.2M	1.7M	1.9M	3.6M	2.8M
Total Current Assets	6.2M	6.8M	5.7M	3.2M	11.7M	10.5M
Common Stock	674.0	1.3K	2.5K	4.6K	30.0	28.5
Common Stock Total Equity	141.0	379.0	674.0	1.3K	1.1K	1.1K
Property Plant And Equipment Gross	8.5K	176.0K	6.0K	294.8K	186.7K	0.0
Accumulated Other Comprehensive Income	(16.2K)	516.0	458.0	(70.0)	(63.0)	(66.15)
Property Plant Equipment	8.5K	6.6K	64.8K	294.8K	265.3K	172.3K
Net Tangible Assets	11.8M	3.8M	4.6M	4.2M	3.8M	3.6M
Retained Earnings Total Equity	(213.5M)	(227.8M)	(236.2M)	(246.0M)	(221.4M)	(232.5M)
Capital Surpluse	222.4M	239.6M	239.9M	250.6M	288.2M	226.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Additional Tools for Tenax Stock Analysis

When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Tenax Historical Balance Sheet

Tenax Therapeutics Inventory

401,964

About Tenax Balance Sheet Analysis

Tenax Therapeutics Balance Sheet Chart

Total Assets

Total Current Liabilities

Tenax Therapeutics balance sheet Correlations

Tenax Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Tenax Therapeutics balance sheet Accounts

Also Currently Popular

Additional Tools for Tenax Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash

Total Current Assets	- 1.0	Net Debt
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Net Debt	- 1.0	Total Stockholder Equity
Net Debt	- 0.99	Total Assets
Other Stockholder Equity	- 0.93	Retained Earnings